Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
LDK378 (Ceritinib)
LDK378(Ceritinib) is a highly selective, orally bioavailable and ATP-competitive small molecule inhibitor of ALK (Anaplastic Lymphoma Kinase), a receptor tyrosine kinase considered to be an important lung cancer drug target. LDK378 displays enhanced potency over Crizotinib and noteworthy antitumor activity for ALK-activated, non-small cell lung cancer (NSCLC).
Catalog NO: CT-LDK378
Synonym: Ceritinib
CAS NO: 1032900-25-6
Mol. Formula: C28H36ClN5O3S
MW: 558.1
** in vivo Grade Material. >99.5% Pure. White Crystalline Solid (pic attached), free base (salt-free), validated by a spot-on quantitative elemental analysis. Bulk stock, prompt.